Atrial Fibrillation Surgery Market Trends

  • Report ID: 4857
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Atrial Fibrillation Surgery Market Trends

Growth Drivers

  • Increasing Technological Advancements in the Field of Atrial Fibrillation Surgery - On account of the increasing technological advances in the field, the market is expected to expand more in the upcoming years. For instance, in 2022, a single lead ECG was developed to use machine learning to help detect patients with atrial fibrillation-induced heart failure.
  • Increasing Number of Digital Catheterization Labs in Hospitals - Advances in catheterization technology such as robot-assisted catheterization for cardiac catheterization have advanced the digital imaging system. This system allows physicians to perform coronary procedures in digital cath labs more effectively, allowing them to detect and treat cardiac disorders. These laboratories provide diagnostic services at hospitals, ambulatory surgical centers, and physician's offices for outpatient procedures. More than 1 million cardiac catheterization procedures are performed every year in the United States, primarily to diagnose and treat patients with suspected coronary heart disease.
  • Rise in People Suffering from Atrial Fibrillation Conditions – according to the data published on July 2022, by the Center for Disease Control and Prevention (CDC), stated that more than 454,000 hospitalizations happen, with atrial fibrillation as the primary diagnosis each year in the United States. The condition contributes to about 158,000 deaths each year in the U.S.
  • Rise in the Use of Catheter Ablation for Cardiac Arrhythmia Treatment – advanced technology is able to now generate very detailed images of heart tissue. This means that surgeons are able to precisely locate arrhythmia, which improves the operation's effectiveness. Surgeons can also use cryoablation, laser, and cryo energy-based ablation instead of RF-based ablation to treat individuals with arrhythmias. In 2020, the CASTLE trial results predicted a reduction of 38% in AF in patients who implanted the device in form of CRTD.

Challenges

  • High cost of ablation catheters- The demand for advanced devices to enhance the safety and efficiency of associated procedures has arisen as a result of the use of catheter ablation in treating atrial fibrillation. However, it is costly to install most of the devices that are enabled with technology such as 3D mapping and remote catheter navigation. This leads to a reduction in the number of individuals who are able to have catheter ablation surgery, especially in emerging countries. This is one of the major factors predicted to slow down the market growth.
  • Lack of skilled professionals
  • Increased preference for pharmaceutical medicines over atrial fibrillation treatment devices

Atrial Fibrillation Surgery Market: Key Insights

 

Base Year

2024

Forecast Year

2025-2037

CAGR

17.4%

Base Year Market Size (2024)

USD 4.1 billion

Forecast Year Market Size (2037)

USD 33 billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4857
  • Published Date: Nov 08, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of atrial fibrillation surgery is assessed at USD 4.67 billion.

The atrial fibrillation surgery market size was valued at USD 4.1 billion in 2024 and is expected to reach USD 33 billion by 2037, registering around 17.4% CAGR during the forecast period i.e., between 2025-2037. Increasing technological advancements, new product launches, rise in people with atrial fibrillation conditions will drive the market growth.

Asia Pacific industry is expected to hold largest revenue share of 32% by 2037, impelled by increasing popularity of the use of minimum-invasive procedures in the region.

The major players in the market include Abbott Laboratories., AtriCure, Inc., Biosense Webster, Inc., Boehringer Ingelheim GmbH, Boston Scientific Corporation, Bristol-Myers Squibb Corporation, CardioFocus, Inc., Endoscopic Technologies, Inc., Sanofi Aventis, Johnson and Johnson Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample